Intellia Therapeutics NTLA
NASDAQ NTLA
$12.16 +0.04 (+0.33%)
As of: Oct 2, 2026 · 12:16 PM EDT

Intellia Therapeutics (NTLA) Depreciation & Amortization (CF) (2015 - 2026)

Updated

Intellia Therapeutics (NTLA) posted Depreciation & Amortization (CF) of $2.1 million for Q2 2026, down 16.0% from $2.5 million a year earlier and down 4.6% from the prior quarter.

Analysis

Intellia Therapeutics (NTLA) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Intellia Therapeutics was $9.1 million, down 10.6% year-over-year; for FY2025, it was $9.8 million, down 4.9% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 9.2% (FY2020 to FY2025).
  • In prior years, Intellia Therapeutics' Depreciation & Amortization (CF) was $10.3 million in FY2024 (+14.4%), $9 million in FY2023 (+18.4%), $7.6 million in FY2022 (+10.1%) and $6.9 million in FY2021 (+9.3%).
  • The Q2 2026 figure stands as the lowest quarterly Depreciation & Amortization (CF) since Q1 2023.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last six quarters, with an average decline of 3.7% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q1 2024, with growth of 22.5%; the weakest was Q2 2026, with a decline of 16.0%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $2.2 million (Q1 2026), $2.4 million (Q4 2025) and $2.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Intellia Therapeutics 1.69 Bn 1.69 Bn - 2.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.10 Mn
Mar 31, 2026 2.20 Mn
Dec 31, 2025 2.40 Mn
Sep 30, 2025 2.40 Mn
Jun 30, 2025 2.50 Mn
Mar 31, 2025 2.50 Mn
Dec 31, 2024 2.58 Mn
Sep 30, 2024 2.60 Mn
Jun 30, 2024 2.60 Mn
Mar 31, 2024 2.51 Mn
Dec 31, 2023 2.49 Mn
Sep 30, 2023 2.29 Mn
Jun 30, 2023 2.17 Mn
Mar 31, 2023 2.05 Mn
Dec 31, 2022 2.06 Mn
Sep 30, 2022 1.95 Mn
Jun 30, 2022 1.84 Mn
Mar 31, 2022 1.75 Mn
Dec 31, 2021 1.89 Mn
Sep 30, 2021 1.79 Mn
API Access

Intellia Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NTLA&period=max&api_key=YOUR_API_KEY